We are live on ! Find out more
SFE

Safeguard Scientifics, Inc.

Delisted

SFE was delisted on the 9th of February, 2024.

4 hedge funds and large institutions have $337K invested in Safeguard Scientifics, Inc. in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

90% less funds holding

Funds holding: 394 (-35)

92% less capital invested

Capital invested by funds: $4.41M → $337K (-$4.07M)

97% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 35

Holders
4
Holders Change
-35
Holders Change %
-89.74%
% of All Funds
0.06%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
1
Reduced
Closed
35
Calls
Puts
Net Calls
Net Calls Change

SFE Hedge Fund Activity: Q1 2024 in Review

4 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Safeguard Scientifics, Inc. (SFE) for Q1 2024, worth a combined $337K — down 92% from $4.41M a quarter earlier.

Sellers outnumbered buyers: 35 funds closed out of SFE and 1 opened new positions — a net loss of 34 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was Clayton Partners, opening a new position worth an estimated $313K. The largest seller was Contrarian Capital Management, exiting entirely with an estimated $941K sold.

  • 4 institutional investors held Safeguard Scientifics, Inc. (SFE) as of Q1 2024, down from 39 in Q4 2023.
  • Funds reported $337K of Safeguard Scientifics, Inc. stock for Q1 2024, down 92% quarter-over-quarter.
  • 1 fund opened new Safeguard Scientifics, Inc. positions in Q1 2024 and 35 closed out, a net change of -34 holders.
  • The largest Safeguard Scientifics, Inc. buyer in Q1 2024 was Clayton Partners, an estimated $313K added.
  • The largest Safeguard Scientifics, Inc. seller in Q1 2024 was Contrarian Capital Management, an estimated $941K sold.

Based on aggregated 13F filings for Q1 2024.